Home

Και ομάδα Αποικιακός Αλληλοσυνδέω ioannis politikos mskcc email για να μην αναφέρω βλήμα ακαμψία

Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan  Kettering Cancer Center | LinkedIn
Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan Kettering Cancer Center | LinkedIn

Guidelines for the Prevention and Management of Graft-versus-Host Disease  after Cord Blood Transplantation - Transplantation and Cellular Therapy,  Official Publication of the American Society for Transplantation and  Cellular Therapy
Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Ioannis Politikos (@ipolitikos) / X
Ioannis Politikos (@ipolitikos) / X

Cytomegalovirus Reactivation Promotes CD8+ T Cell Subset Recovery after  Unmodified Allogeneic Hematopoietic Cell Transplantation - Biology of Blood  and Marrow Transplantation
Cytomegalovirus Reactivation Promotes CD8+ T Cell Subset Recovery after Unmodified Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation

Cellular Therapy During COVID-19: Lessons Learned and Preparing for  Subsequent Waves - Transplantation and Cellular Therapy, Official  Publication of the American Society for Transplantation and Cellular Therapy
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Extended-duration letermovir prophylaxis for cytomegalovirus infection  after cord blood transplantation in adults - ScienceDirect
Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults - ScienceDirect

Ioannis Politikos (@ipolitikos) / X
Ioannis Politikos (@ipolitikos) / X

Hematopoietic Cell Transplantation is Feasible in Patients with Prior  COVID-19 Infection - Transplantation and Cellular Therapy, Official  Publication of the American Society for Transplantation and Cellular Therapy
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan  Kettering Cancer Center | LinkedIn
Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan Kettering Cancer Center | LinkedIn

PDF) A Novel Reduced-Intensity Conditioning Regimen Induces a High  Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment  after Double-Unit Cord Blood Transplantation
PDF) A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit Cord Blood Transplantation

JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell  transplantation
JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Dr. Ioannis Politikos, MD | New York, NY | Oncologist
Dr. Ioannis Politikos, MD | New York, NY | Oncologist

JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell  transplantation
JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous  Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular  Therapy - Transplantation and Cellular Therapy, Official Publication of the  American Society for
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for

Gunjan SHAH | Assistant Attending | Memorial Sloan Kettering Cancer Center,  New York City | MSKCC | Bone Marrow Transplant Service | Research profile
Gunjan SHAH | Assistant Attending | Memorial Sloan Kettering Cancer Center, New York City | MSKCC | Bone Marrow Transplant Service | Research profile

Ioannis Politikos, MD - MSK Bone Marrow Transplant Specialist
Ioannis Politikos, MD - MSK Bone Marrow Transplant Specialist

Pocket Oncology
Pocket Oncology

Post-Transplantation Cyclophosphamide Is Associated with an Increase in  Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia  and Myelodysplastic Syndrome - Transplantation and Cellular Therapy,  Official Publication of the American ...
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome - Transplantation and Cellular Therapy, Official Publication of the American ...

Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult  Cord Blood Transplantation - Biology of Blood and Marrow Transplantation
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation - Biology of Blood and Marrow Transplantation

Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose,  and 8-Allele HLA Match by Patient Ancestry - Biology of Blood and Marrow  Transplantation
Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry - Biology of Blood and Marrow Transplantation

Genovefa Papanicolaou's research works | Memorial Sloan Kettering Cancer  Center, New York City (MSKCC) and other places
Genovefa Papanicolaou's research works | Memorial Sloan Kettering Cancer Center, New York City (MSKCC) and other places

Evangelos Ntrivalas - Assistant Attending Immunologist, Cellular  Immunology, Department of Laboratory Medicine - Memorial Sloan Kettering  Cancer Center | LinkedIn
Evangelos Ntrivalas - Assistant Attending Immunologist, Cellular Immunology, Department of Laboratory Medicine - Memorial Sloan Kettering Cancer Center | LinkedIn

JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell  transplantation
JCI - Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an  Increased Risk of Transplant-Related Mortality (TRM) or Inferior  Progression-Free Survival (PFS) after Double Unit Cord Blood (CB)  Transplantation (dCBT) in Adults with Hematologic
Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic

Jessica FLYNN | Research Biostatistician | Master of Science | Memorial  Sloan Kettering Cancer Center, New York City | MSKCC | Epidemiology &  Biostatistics Group | Research profile
Jessica FLYNN | Research Biostatistician | Master of Science | Memorial Sloan Kettering Cancer Center, New York City | MSKCC | Epidemiology & Biostatistics Group | Research profile

Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan  Kettering Cancer Center | LinkedIn
Ioannis Politikos - Assistant Member, Adult BMT Service - Memorial Sloan Kettering Cancer Center | LinkedIn